Supplemental Material - Novel 5-HT7 receptor antagonists modulate intestinal immune responses and reduce severity of colitis
Published: 18 April 2024| Version 1 | DOI: 10.17632/vwycbkk9x2.1
Contributor:
Waliul KhanDescription
Supplementary Material for the paper entitled "Novel 5-HT7 receptor antagonists modulate intestinal immune responses and reduce severity of colitis" by Kwon et al.
Files
Institutions
McMaster University
Categories
Inflammatory Bowel Disease, Serotonin Receptor Affecting Agent, Serotonin
Funding
Canadian Institutes of Health Research
PJT156262
Crohn's and Colitis Foundation
510490